Whitehawk Therapeutics Inc Share Price

NASDAQ: WHWK

Small Cap

$1.97

+0.02

(+1.03%)

as on September 18, 2025 at 1:29 am IST

$₹

Whitehawk Therapeutics Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$1.9
Day's Price Range
$2
$1.97
3.55%
Downside
1.52%
Upside
52 Week's Low
52 Week's High
$1.39
52-Week Price Range
$2.2
$1.97
29.44%
Downside
11.68%
Upside

Whitehawk Therapeutics Inc share price movements today

Previous Close: $1.95
Open: $1.92
Volume: 3.8M
Day's Low - High: $1.9 - $2
52 Week Low - High: $1.39 - $2.2

Whitehawk Therapeutics Inc Historical Returns

1 Month Return: + 21.87 %
3 Month Return: -2.99 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Whitehawk Therapeutics Inc Stock Fundamentals & Key Indicators

Check Whitehawk Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$87.2M

EPS (TTM)

-0.74

Dividend Yield

0.00%

PE Ratio (TTM)

12.33

Industry PE ratio

P/B Ratio

12.3333

PEG Ratio

Return On Equity TTM

17.69%

Whitehawk Therapeutics Inc Stock Valuation

Track how Whitehawk Therapeutics Inc P/E has moved over time to understand its valuation trends.

Whitehawk Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 17, 2025

Industry (0.00x)

September 17, 2025

Today (12.33x)

September 17, 2025

Highest (0.00x)

September 17, 2025

LowHigh

Today’s Price to Earnings Ratio: 12.33x

Whitehawk Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Whitehawk Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Whitehawk Therapeutics Inc	NA	$87.2M	NA	12.33	99.42%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Whitehawk Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Whitehawk Therapeutics Inc Stock has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-57% versus previous 30 day period

Whitehawk Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	5	6	5	6	5	6	7	7	7	-
Gross Profit	5	-7	-6	-7	-8	-7	-3	-7	6	-
Operating Income	-16	-19	-17	-17	-19	-15	-13	-18	-15	-54
EBITDA	-15	-19	-17	-17	-19	-15	-10	-18	-15	-52
Interest Expense	0	-	0	0	0	0	0	-	-	-
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-15	-17	-16	-16	-18	-14	-12	-18	73	-52
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-15	-17	-16	-16	-18	-14	-12	-18	73	-52
Net Profit Margin	-259.47%	-289.76%	-273.57%	-257.18%	-341.66%	-236.01%	-173.96%	-252.42%	1021.92%	0.00%

Whitehawk Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	14	1	15	24	25
Gross Profit	-10	0	-18	-18	-27	-28
Operating Income	-12	-2	-111	-62	-71	-67
EBITDA	-12	-2	-36	-58	-71	-64
Interest Expense	-	0	0	0	0	0
Depreciation	-	0	0	0	0	0
Income Before Tax	-12	-3	-110	-60	-65	-63
Income Tax Expense	0	0	0	-	-	-
Net Income	-12	-3	-110	-60	-65	-63
Net Profit Margin	-1636.19%	-23.85%	-9829.46%	-397.69%	-270.04%	-245.13%

Whitehawk Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-17	-16	-16	-18	-14	-12	-18	73	-52
Operating Cash Flow	-16	-11	-9	-19	-9	-15	-15	-11	-52
Investing Cash Flow	50	12	3	10	-3	5	13	115	-28
Financing Cash Flow	0	0	0	0	0	-	0	95	0
Change in Cash	34	0	-5	-9	-12	-10	-1	198	-82

Whitehawk Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-3	-110	-60	-65	-63
Operating Cash Flow	-12	-22	-49	-59	-59
Investing Cash Flow	-	25	-132	83	25
Financing Cash Flow	1	141	72	0	0
Change in Cash	-11	144	-109	23	-34

Insights on Whitehawk Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, WHWK stock has moved up by 8.9%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 200.9%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 62.1%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 73.01M → -52.61M (in $), with an average decrease of 172.1% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 7.23M → 7.14M (in $), with an average decrease of 1.3% per quarter

About Whitehawk Therapeutics Inc

Whitehawk Therapeutics, Inc., formerly Aadi Bioscience, Inc., is a preclinical stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Its advanced three-asset antibody drug conjugate (ADC) portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. Its assets include HWK-007, HWK-016 and HWK-206. HWK-007 represents a differentiated opportunity to potentially be among the first next-wave ADCs in clinical development for high PTK7-expressing cancers. HWK-016 is the first ADC that targets the membrane-bound portion of MUC16, a glycoprotein often overexpressed in cancers of female origin. HWK-016 is being evaluated in IND-enabling studies. HWK-206 is designed to address the neuronal target, SEZ6, which is often overexpressed in cancers of neuroendocrine origin.

Organisation	Whitehawk Therapeutics Inc
Headquarters	2 Headquarters Plaza, Morristown, NJ, United States, 07960
CEO	Dr. David J. Lennon Ph.D.
E-voting on shares	Click here to vote

Key Management of Whitehawk Therapeutics Inc

Name	Title
Mr. Bryan Ball	Chief Technical Operations Officer
Dr. David Dornan Ph.D.	Chief Scientific Officer
Mr. Stephen M. Rodin J.D.	Senior VP of Legal & General Counsel
Dr. David J. Lennon Ph.D.	President, CEO & Director
Dr. Neil P. Desai Ph.D.	Founder & Director
Mr. Scott M. Giacobello CPA	CFO, Treasurer, Investor Relations & Corporate Communications

FAQs

What is Whitehawk Therapeutics Inc share price today?

Whitehawk Therapeutics Inc share price today is $1.97 as on September 18, 2025 at 1:29 am IST at the close of the market. Whitehawk Therapeutics Inc share today touched a day high of $2 and a low of $1.9.

What is the 52 week high and 52 week low for Whitehawk Therapeutics Inc share?

Whitehawk Therapeutics Inc share touched a 52 week high of $2.2 on May 20, 2025 and a 52 week low of $1.39 on April 25, 2025. Whitehawk Therapeutics Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $1.97,which is 10.45% down from its 52 week high and 41.73% up from its 52 week low.

What is Whitehawk Therapeutics Inc's market capitalisation today?

Whitehawk Therapeutics Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Whitehawk Therapeutics Inc Stock (WHWK) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Whitehawk Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Whitehawk Therapeutics Inc Shares that will get you 0.7614 shares as per Whitehawk Therapeutics Inc share price of $1.97 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Whitehawk Therapeutics Inc Stock (WHWK) from India?

Indian investors can start investing in Whitehawk Therapeutics Inc (WHWK) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 4:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Whitehawk Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 4:38 am IST). Based on Whitehawk Therapeutics Inc share’s latest price of $1.97 as on September 18, 2025 at 1:29 am IST, you will get 5.0761 shares of Whitehawk Therapeutics Inc. Learn more about fractional shares .